204 related articles for article (PubMed ID: 37515199)
1. Impact of Alteplase on Mortality in Critically Ill Patients with COVID-19 and Pulmonary Embolism.
Oliynyk OV; Rorat M; Solyarik SO; Lukianchuk VA; Dubrov SO; Guryanov VH; Oliynyk YV; Yaroslavskaya SM; Szalast R; Barg W
Viruses; 2023 Jul; 15(7):. PubMed ID: 37515199
[TBL] [Abstract][Full Text] [Related]
2. Comparative Efficacy and Safety of Thrombolytic Agents for Pulmonary Embolism: A Bayesian Network Meta-Analysis.
Li HY; Wang YB; Ren XY; Wang J; Wang HS; Jin YH
Pharmacology; 2023; 108(2):111-126. PubMed ID: 36603558
[TBL] [Abstract][Full Text] [Related]
3. Thrombolysis in severe COVID-19 pneumonia with massive pulmonary embolism.
Alharthy A; Faqihi F; Papanikolaou J; Balhamar A; Blaivas M; Memish ZA; Karakitsos D
Am J Emerg Med; 2021 Mar; 41():261.e1-261.e3. PubMed ID: 32763101
[TBL] [Abstract][Full Text] [Related]
4. Study of Alteplase for Respiratory Failure in SARS-CoV-2 COVID-19: A Vanguard Multicenter, Rapidly Adaptive, Pragmatic, Randomized Controlled Trial.
Barrett CD; Moore HB; Moore EE; Wang J; Hajizadeh N; Biffl WL; Lottenberg L; Patel PR; Truitt MS; McIntyre RC; Bull TM; Ammons LA; Ghasabyan A; Chandler J; Douglas IS; Schmidt EP; Moore PK; Wright FL; Ramdeo R; Borrego R; Rueda M; Dhupa A; McCaul DS; Dandan T; Sarkar PK; Khan B; Sreevidya C; McDaniel C; Grossman Verner HM; Pearcy C; Anez-Bustillos L; Baedorf-Kassis EN; Jhunjhunwala R; Shaefi S; Capers K; Banner-Goodspeed V; Talmor DS; Sauaia A; Yaffe MB
Chest; 2022 Mar; 161(3):710-727. PubMed ID: 34592318
[TBL] [Abstract][Full Text] [Related]
5. Salvage use of tissue plasminogen activator (tPA) in the setting of acute respiratory distress syndrome (ARDS) due to COVID-19 in the USA: a Markov decision analysis.
Choudhury R; Barrett CD; Moore HB; Moore EE; McIntyre RC; Moore PK; Talmor DS; Nydam TL; Yaffe MB
World J Emerg Surg; 2020 Apr; 15(1):29. PubMed ID: 32312290
[TBL] [Abstract][Full Text] [Related]
6. Treatment of pulmonary embolism with argatroban and ultrasound-assisted catheter-directed thrombolysis with alteplase in a patient with heparin-induced thrombocytopenia.
Bethea BT; Elliot JW; Richardson JB; Ahmed MI
Am J Health Syst Pharm; 2017 Aug; 74(15):1153-1157. PubMed ID: 28743779
[TBL] [Abstract][Full Text] [Related]
7. Should thrombolytic therapy be used in patients with pulmonary embolism?
Konstantinides S
Am J Cardiovasc Drugs; 2004; 4(2):69-74. PubMed ID: 15049719
[TBL] [Abstract][Full Text] [Related]
8. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA
Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777
[TBL] [Abstract][Full Text] [Related]
9. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism.
Konstantinides S; Geibel A; Heusel G; Heinrich F; Kasper W;
N Engl J Med; 2002 Oct; 347(15):1143-50. PubMed ID: 12374874
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary embolism or thrombosis in ARDS COVID-19 patients: A French monocenter retrospective study.
Contou D; Pajot O; Cally R; Logre E; Fraissé M; Mentec H; Plantefève G
PLoS One; 2020; 15(8):e0238413. PubMed ID: 32853267
[TBL] [Abstract][Full Text] [Related]
11. PAIMS 2: alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen activator Italian multicenter study 2.
Dalla-Volta S; Palla A; Santolicandro A; Giuntini C; Pengo V; Visioli O; Zonzin P; Zanuttini D; Barbaresi F; Agnelli G
J Am Coll Cardiol; 1992 Sep; 20(3):520-6. PubMed ID: 1512328
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of inhaled nitric oxide (iNO) treatment for moderate-to-severe ARDS in critically ill patients with COVID-19: a multicenter cohort study.
Al Sulaiman K; Korayem GB; Altebainawi AF; Al Harbi S; Alissa A; Alharthi A; Kensara R; Alfahed A; Vishwakarma R; Al Haji H; Almohaimid N; Al Zumai O; Alrubayan F; Asiri A; Alkahtani N; Alolayan A; Alsohimi S; Melibari N; Almagthali A; Aljahdali S; Alenazi AA; Alsaeedi AS; Al Ghamdi G; Al Faris O; Alqahtani J; Al Qahtani J; Alshammari KA; Alshammari KI; Aljuhani O
Crit Care; 2022 Oct; 26(1):304. PubMed ID: 36192801
[TBL] [Abstract][Full Text] [Related]
13. Study of alteplase for respiratory failure in severe acute respiratory syndrome coronavirus 2/COVID-19: Study design of the phase IIa STARS trial.
Moore HB; Barrett CD; Moore EE; Jhunjhunwala R; McIntyre RC; Moore PK; Wang J; Hajizadeh N; Talmor DS; Sauaia A; Yaffe MB
Res Pract Thromb Haemost; 2020 Aug; 4(6):984-996. PubMed ID: 32838109
[TBL] [Abstract][Full Text] [Related]
14. Fixed-Dose Ultrasound-Assisted Catheter-Directed Thrombolysis for Acute Pulmonary Embolism Associated with COVID-19.
Voci D; Zbinden S; Micieli E; Kucher N; Barco S
Viruses; 2022 Jul; 14(8):. PubMed ID: 35893672
[No Abstract] [Full Text] [Related]
15. Empirical systemic anticoagulation is associated with decreased venous thromboembolism in critically ill influenza A H1N1 acute respiratory distress syndrome patients.
Obi AT; Tignanelli CJ; Jacobs BN; Arya S; Park PK; Wakefield TW; Henke PK; Napolitano LM
J Vasc Surg Venous Lymphat Disord; 2019 May; 7(3):317-324. PubMed ID: 30477976
[TBL] [Abstract][Full Text] [Related]
16. Risk factors associated with bleeding after alteplase administration for pulmonary embolism: a case-control study.
Curtis GM; Lam SW; Reddy AJ; Bauer SR
Pharmacotherapy; 2014 Aug; 34(8):818-25. PubMed ID: 24854996
[TBL] [Abstract][Full Text] [Related]
17. [Tissue plasminogen activator (alteplase) in acute massive pulmonary embolism. A pilot study].
Lang M; Charbonnier B; Quilliet L; Pacouret G; Poitrineau O; Mannara R; Neel G; Desveaux B; Raynaud P; Brochier ML
Arch Mal Coeur Vaiss; 1989 Nov; 82(11):1803-11. PubMed ID: 2514632
[TBL] [Abstract][Full Text] [Related]
18. Comparison of alteplase versus heparin for resolution of major pulmonary embolism.
Konstantinides S; Tiede N; Geibel A; Olschewski M; Just H; Kasper W
Am J Cardiol; 1998 Oct; 82(8):966-70. PubMed ID: 9794353
[TBL] [Abstract][Full Text] [Related]
19. Acute pulmonary embolism and systemic thrombolysis in the era of COVID-19 global pandemic 2020: a case series of seven patients admitted to a regional hospital in the French epidemic cluster.
Philippe J; Cordeanu EM; Leimbach MB; Greciano S; Younes W
Eur Heart J Case Rep; 2021 Feb; 5(2):ytaa522. PubMed ID: 33594346
[TBL] [Abstract][Full Text] [Related]
20. Limitations of the ARDS criteria during high-flow oxygen or non-invasive ventilation: evidence from critically ill COVID-19 patients.
Hultström M; Hellkvist O; Covaciu L; Fredén F; Frithiof R; Lipcsey M; Perchiazzi G; Pellegrini M
Crit Care; 2022 Mar; 26(1):55. PubMed ID: 35255949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
